Table 2.

Tumor response and overall survival of BCLC-C advanced HCC patients.

	Tumor response rate (per target lesion) at 1st follow-up within 3 months
Complete Response	27/86 (31.4%)
Partial Response	23/86 (26.7%)
Stable Disease	26/86 (30.2%)
Progressivea Disease	10/86 (11.6%)
Objective Response	58.1%
Disease Control Rate	88.4%
OS/person (per patient)
Median OS (months)	15.9 ± 8.7
1-year OS rate	38/64 (59.3%)
2-year OS rate	14/64 (21.8%)

OS: Overall Survival, BCLC: Barcelona Clinic Liver Cancer.